Given that PKD1 is positioned at the crossroad between stimulation of cardiac glucose uptake and hypertrophic signaling and that hypertrophy can be beneficial short-term, we sought to look downstream of PKD1 and to directly target cardiac metabolism rather than cardiac hypertrophy. This evidence concerns the gene PKD1 and cardiac hypertrophy.